Unsurprisingly, microRNAs dominate the list of highest cited papers, and the area is witnessing rapid growth. The number of papers in other fields, such as proteomics, nanotech and RNA interference, also continues to expand; 80% of the publications specifically reporting cancer stem cells were published in the past two years. China and India continue to increase their output of biotech papers; France fell behind Spain and Italy; Switzerland entered the top 15 for the first time.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taroncher-Oldenburg, G., Marshall, A. Trends in biotech literature 2006. Nat Biotechnol 25, 961 (2007). https://doi.org/10.1038/nbt0907-961
Issue Date:
DOI: https://doi.org/10.1038/nbt0907-961
This article is cited by
-
Why commercialization of gene therapy stalled; examining the life cycles of gene therapy technologies
Gene Therapy (2014)
-
Transfection of shRNA-encoding Minivector DNA of a few hundred base pairs to regulate gene expression in lymphoma cells
Gene Therapy (2011)
-
Can literature analysis identify innovation drivers in drug discovery?
Nature Reviews Drug Discovery (2009)
